Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Annual Review of Pathology|October 26, 2021
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic ImplicationsMengxiong Wang, Laura D Attardi
Critical Reviews in Oncology/Hematology|June 13, 2018
The unfolded protein response as a target for anticancer therapeuticsMengxiong Wang, Mary E Law, Ronald K Castellano, et al.
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Inhibition of cotranslational translocation by apratoxin S4: Effects on oncogenic receptor tyrosine kinases and the fate of transmembrane proteins produced in the cytoplasmWeijing Cai, Ranjala Ratnayake, Mengxiong Wang, et al.
Genes & Development|June 18, 2025
Analysis of knockout mice reveals critical female-specific roles for the Hippo pathway component PTPN14Edel M McCrea, Neoklis Makrides, Takako Tabata, et al.
Frontiers in Pharmacology|January 31, 2022
Repurposing Tranexamic Acid as an Anticancer AgentMary E Law, Bradley J Davis, Amanda F Ghilardi, et al.
Cell Death Discovery|December 17, 2019
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathwayMengxiong Wang, Mary E Law, Bradley J Davis, et al.
Oncotarget|April 21, 2017
Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cellsRenan B Ferreira, Mengxiong Wang, Mary E Law, et al.
Oncogene|February 6, 2019
A novel proteotoxic combination therapy for EGFR+ and HER2+ cancersMengxiong Wang, Renan B Ferreira, Mary E Law, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Activating p53Y220C with a Mutant-Specific Small MoleculeXijun Zhu, Woong Sub Byun, Dominika Ewa Pieńkowska, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
DR5 disulfide bonding as a sensor and effector of protein folding stressMary E Law, Zaafir M Dulloo, Samantha R Eggleston, et al.
Pageof 2